Rena Barrow has two sons with cystic fibrosis, born 20 years apart — but they faced the same terrible delay in diagnosis.
Spirovant Sciences has announced the commencement of its SAAVe Phase I/II study, with the first patient receiving a dose of ...
ReCode is set to secure up to $15m in funding from the Cystic Fibrosis Foundation to enhance its gene correction research ...
The parents of a four-year-old boy with cystic fibrosis whose gene pairing makes him "one of 50 cases in the world" have ...
The Cystic Fibrosis Foundation is funding the development of a gene editing therapy that is designed to use ReCode’s ...
The firm's chief scientific officer called the achievement "a major milestone for Spirovant and for the cystic fibrosis ...
"There is a grey cloud there, but there are ways of managing that grey cloud, there are ways to plan for it and there are ...
BETHESDA, Md.--(BUSINESS WIRE)--The Cystic Fibrosis Foundation has agreed to invest up to $15 million in ReCode Therapeutics to support their gene editing collaboration with Intellia Therapeutics.
The parents of a four-year-old boy with cystic fibrosis whose gene pairing makes him "one of 50 cases in the world" have ...